Rosen Firm is at it again. This time they are going after Neurotrope NTRP, a company that, like AVXL, is trying to develop an Alzheimer's drug that is NOT based on the same failed ideas of every other Alzheimer's drug.

http://www.prnewswire.com/news-releases/equit...83613.html